Safety and immunogenicity of SW-BIC-213, a modified COVID-19 Lipo-Polyplex mRNA vaccine, in Laotian healthy adults aged 18 years and above: a Phase 1/2 trial
Yujie Chen, Jingxin Li, Davone Duangdany, Chanthala Phamisith, Bo Yu, Shengke Lan, Lairun Jin, Dawei Lv, Yang Li, Bin Luo, Peng Han, Jinyan Wu, Yuzhu Wang, Congcong Xu, Mingyun Shen, Fanfan Zhao, Peipei Liu, Rongjuan Pei, Haifa Shen, Wuxiang Guan, Hangwen Li, Mayfong Mayxay
doi: https://doi.org/10.1101/2023.09.11.23295344
Yujie Chen
1Stemirna Therapeutics, Shanghai, China
Jingxin Li
2Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China
Davone Duangdany
3Food and Drug Department, Ministry of Health, Vientiane, Laos
Chanthala Phamisith
4Savannakhet Province Hospital, Savannakhet, Laos
Bo Yu
1Stemirna Therapeutics, Shanghai, China
Shengke Lan
1Stemirna Therapeutics, Shanghai, China
Lairun Jin
2Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China
Dawei Lv
1Stemirna Therapeutics, Shanghai, China
Yang Li
1Stemirna Therapeutics, Shanghai, China
Bin Luo
1Stemirna Therapeutics, Shanghai, China
Peng Han
1Stemirna Therapeutics, Shanghai, China
Jinyan Wu
1Stemirna Therapeutics, Shanghai, China
Yuzhu Wang
1Stemirna Therapeutics, Shanghai, China
Congcong Xu
1Stemirna Therapeutics, Shanghai, China
Mingyun Shen
1Stemirna Therapeutics, Shanghai, China
Fanfan Zhao
1Stemirna Therapeutics, Shanghai, China
Peipei Liu
5Chinese center for disease control and prevention, China
Rongjuan Pei
6Wuhan Institute of Virology, Wuhan, China
Haifa Shen
1Stemirna Therapeutics, Shanghai, China
Wuxiang Guan
6Wuhan Institute of Virology, Wuhan, China
Hangwen Li
1Stemirna Therapeutics, Shanghai, China
Mayfong Mayxay
7Institute of Research and Education Development, University of Health Sciences, Vientiane, Lao People’s Democratic Republic
Article usage
Posted September 12, 2023.
Safety and immunogenicity of SW-BIC-213, a modified COVID-19 Lipo-Polyplex mRNA vaccine, in Laotian healthy adults aged 18 years and above: a Phase 1/2 trial
Yujie Chen, Jingxin Li, Davone Duangdany, Chanthala Phamisith, Bo Yu, Shengke Lan, Lairun Jin, Dawei Lv, Yang Li, Bin Luo, Peng Han, Jinyan Wu, Yuzhu Wang, Congcong Xu, Mingyun Shen, Fanfan Zhao, Peipei Liu, Rongjuan Pei, Haifa Shen, Wuxiang Guan, Hangwen Li, Mayfong Mayxay
medRxiv 2023.09.11.23295344; doi: https://doi.org/10.1101/2023.09.11.23295344
Safety and immunogenicity of SW-BIC-213, a modified COVID-19 Lipo-Polyplex mRNA vaccine, in Laotian healthy adults aged 18 years and above: a Phase 1/2 trial
Yujie Chen, Jingxin Li, Davone Duangdany, Chanthala Phamisith, Bo Yu, Shengke Lan, Lairun Jin, Dawei Lv, Yang Li, Bin Luo, Peng Han, Jinyan Wu, Yuzhu Wang, Congcong Xu, Mingyun Shen, Fanfan Zhao, Peipei Liu, Rongjuan Pei, Haifa Shen, Wuxiang Guan, Hangwen Li, Mayfong Mayxay
medRxiv 2023.09.11.23295344; doi: https://doi.org/10.1101/2023.09.11.23295344
Subject Area
Subject Areas
- Addiction Medicine (373)
- Allergy and Immunology (690)
- Anesthesia (184)
- Cardiovascular Medicine (2760)
- Dermatology (236)
- Emergency Medicine (414)
- Epidemiology (12413)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4272)
- Geriatric Medicine (396)
- Health Economics (702)
- Health Informatics (2761)
- Health Policy (1021)
- Hematology (370)
- HIV/AIDS (880)
- Medical Education (404)
- Medical Ethics (112)
- Nephrology (454)
- Neurology (4054)
- Nursing (218)
- Nutrition (600)
- Oncology (2134)
- Ophthalmology (607)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (479)
- Pediatrics (1150)
- Primary Care Research (470)
- Public and Global Health (6663)
- Radiology and Imaging (1453)
- Respiratory Medicine (886)
- Rheumatology (422)
- Sports Medicine (353)
- Surgery (465)
- Toxicology (57)
- Transplantation (192)
- Urology (171)